目的:產氣單胞桿菌屬細菌並不是常見的感染病症，但卻可以造成嚴重致命的感染。
方法:從連續六年間(2003/1/1至2008/12/31)在台東馬偕醫院被診斷出產氣單胞桿菌屬菌血症的48位病患中分析其人口統計學，臨床表徵，實驗檢驗數據及最終結果。
結果:共39位男性和9位女性病患。在這群48位病人其中，有36位是單一菌種感染而其餘12位是多重細菌感染。病患最常見的症狀為發燒(43/48' 90%)黃痘(28/48 ' 58%)及腹痛(25/48 ' 52%)。此外48位病患本身病 史上，擁有肝硬化者(27/峙，56%) ，惡性腫瘤者(7/48'凹的。實驗研究上產氣單胞桿菌屬對抗生素的有效敏感測試如下Gentamycin(100%)，Quinolone (98%) ，Chloramphenicol (98%) ，Cefuroxime (94%) ，Cefotaxime (94%)。 對Ampicillin抗藥性是(98%)。
結論:產氣單胞桿菌屬細菌好發於肝硬化或是惡性腫瘤的病人身上，而且預後並不好。總粗死亡率是15/峙，31%。貧血，白血球增多，腎功能受損是獨立重要的死亡危險因子。

Background: While uncommon, Aeromonas hydrophila bacteremia can be fatal.
Method: From January 1, 2003 to December 31, 2008, 48 patients (39 males, 9 females) diagnosed with A. hydrophila bacteremia were admitted to Mackay Memorial Hospital in Taitung. Patient demographic data, clinical features, laboratory data, and outcomes were retrospectively analyzed.
Result: Of the 48 cases of A. hydrophila bacteremia, 36 were monomicrobial and 12 were polymicrobial infections. The most common symptoms were fever (43/48, 90%), jaundice (28/48, 58%), and abdomen pain (25/48, 52%). Underlying diseases included liver cirrhosis (27/48, 56%), and malignancy (7/48, 15%). In vitro, A. hydrophila was generally susceptible to gentamycin (100%), quinolones (98%), chloramphenicol (98%), cefuroxime (94%), and cefotaxime (94%) and resistant to ampicillin (98%). A. hydrophila bacteremia usually occurred in patients with liver cirrhosis or malignancy and heralded a poor prognosis. The overall crude fatality rate was (15/48, 31%). Anemia, leukocytosis, and impaired renal function were independent significant risk factors of death.
Conclusion: A. hydrophila, although not common, can cause notable rates of morbidity and mortality among immunocompetent and immunocompromised persons. It is important to have a high index of suspicion and increase awareness of A. hydrophila infection at initial presentation. Prompt diagnosis and early treatment with adequate antibiotics are vital.